IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab

Author： Gedebjerg Anne   Johansen Claus   Kragballe Knud   Iversen Lars  

Publisher： Medical Journals Limited

ISSN： 0001-5555

Source： Acta Dermato-Venereologica, Vol.93, Iss.2, 2013-03, pp. : 150-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ustekinumab for the treatment of HIV psoriasis

By Paparizos Vasileios   Rallis Efstathios   Kirsten Leuow   Kyriakis Kyriakos  

Journal of Dermatological Treatment, Vol. 23, Iss. 6, 2012-12 ,pp. : 398-399

Informa Healthcare

Access to resources Recommend Favorite

Sterile Trauma to Normal Human Dermis Invariably Induces IL 1β, IL6 and IL8 in an Innate Response to “Danger”

By Sjögren Florence   Anderson Chris D.  

Acta Dermato-Venereologica, Vol. 89, Iss. 5, 2009-09 ,pp. : 459-465

Medical Journals Limited

Access to resources Recommend Favorite

Concurrent treatment of chronic psoriasis and asthma with ustekinumab

By Amarnani Ajay   Rosenthal Ken S.   Mercado Jorge M.   Brodell Robert T.  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 63-66

Informa Healthcare

Access to resources Recommend Favorite

Differential Response of Chronic Plaque Psoriasis to Briakinumab vs. Ustekinumab

By Inzinger Martin   Weger Wolfgang   Salmhofer Wolfgang   Wolf Peter  

Acta Dermato-Venereologica, Vol. 92, Iss. 4, 2012-07 ,pp. : 357-358

Medical Journals Limited

Access to resources Recommend Favorite

Recurrent Erythema Annulare Centrifugum During Ustekinumab Treatment in a Psoriatic Patient

By Chou Wei-Ting   Tsai Tsen-Fang  

Acta Dermato-Venereologica, Vol. 93, Iss. 2, 2013-03 ,pp. : 208-209

Medical Journals Limited

Access to resources Recommend Favorite